International Cannabis Weekly: 19
November 9, 2017
Highlights
Share this story
Business & Investment
- Big tobacco, alcohol and pharma companies could be poised to enter the cannabis industry.
- Tilray has become the first company to import live cannabis genetics into Europe.
- CannTrust have received approval to export medical cannabis and are now eyeing the German and Danish markets.
- Hoban Law, a Denver-based cannabis law firm, are planning European expansion.
- IBM proposes blockchain as cannabis seed-to-sale tracking solution.
Highlights
Share this story
Regulations & Politics
- The new Netherlands coalition government is backing legalised cannabis production.
- Luxembourg has moved closer to medical cannabis legalisation by announcing plans for a two-year trial.
- Last year, a 60-year ban was lifted. Now Greece’s hemp industry is experiencing a rebirth.
- The legal sale of cannabis in Switzerland could generate hundreds of millions of Swiss francs in tax revenues.
- The legalisation of cannabis could provide a lifeline for the UK’s struggling NHS.
- Trials of a new cannabis inhaler are showing early signs of success in the UK.
Highlights
Share this story
The European Cannabis Report
Medical Cannabis Legislation
Europe has become a hotbed for new market development in medical cannabis. Legislative bills are currently being prepared in at least five separate countries.
Germany has already taken the lead by creating the region’s first legal and regulated medical market. It is paving the way for other countries to follow.
Insights
on the global cannabis industry
International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.